Abnova is one of the world’s largest antibody manufacturer, able to generate 300 mouse monoclonal antibodies and 200 rabbit polyclonal antibodies per month.
Abnova – innovation through integrated solutions
After the completion of human genome sequencing, most human expressed genes have been identified, and full-length cDNA of these genes are now publicly available. In order to understand all these proteins, antibodies with their inherent sensitivity and specificity thus became necessary tools for providing one-to-one relationship with their target proteins. Abnova offers a unique complete monoclonal antibody and protein experience, different from traditional custom production companies and laboratories. Rather than the traditional method of antibody production, Abnova is taking a genomic/proteomic approach for antibodies development. Abnova aims to have at least one antibody for every human expressed gene. Furthermore, Abnova develops a high throughput protein production system (Wheat Germ In Vitro Protein Expression System), allowing soluble expression protein either from full-length cDNA or specific domains, with the correct conformation.
The core of Abnova’s integration is the generation and availability of antibodies and proteins targeting the human genome. Abnova has successfully implemented these integrated solutions for research community and industry. These invaluable bio-tools are combined and used in a comprehensive repertoire of qualitative, quantitative, multiplexing, high throughput, and profiling applications to address the needs of researchers.
Abnova is a biotech company based in Taiwan, USA and Germany. Abnova maintains a streamlined monoclonal production facility with scalable capacity for up to 500 immunization per month, and a Specific Pathogen Free (SPF) facility, which has holding capacity for more than 10.000 mice. These facilities allow Ab-nova to significantly bring down the cost of customized monoclonal antibody production. Abnova also incorporated numerous automation systems into its production line, significantly increasing its efficiency.
More about this biotech company : www.abnova.com